Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Soparkar Peter, Executive. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 9 reports have been recorded. Split: 3 buys · 3 sells. Total volume traded: €253k. Activity tracked since 6 August 2021. The latest transaction was filed on 5 December 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Soparkar Peter is an insider, Chief Operating Officer at Adverum Biotechnologies, Inc. (XNAS). He has 9 filings in total, and across the sampled recent filings the amounts are EUR 223757 in buys and EUR 29213 in sells, covering the period from 2021-08-10 to 2025-12-10.